Retatrutide

Retatrutide is an experimental drug for obesity developed by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist. Wikipedia

• CAS Number:  2381089-83-2
• ATC code:  ATC code
• UNII:  NOP2Y096GV
• ChEMBL:  CHEMBL5095485
• Synonyms:  LY-3437943
• Data source:  DuckDuckGo